- Development of submicromolar 17 beta-HSD10 inhibitors and their in vitro and in vivo evaluation2023 | First Faculty of Medicine
- Novel benzothiazole-based ureas as 17 beta-HSD10 inhibitors, a potential Alzheimer's disease treatment2019 | Publication without faculty affiliation
- Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17 beta-HSD10 modulators for Alzheimer's disease treatment2016 | Publication without faculty affiliation
- 6-Benzothiazolyl ureas, thioureas and guanidines are potent inhibitors of ABAD/17 beta-HSD10 and potential drugs for Alzheimer's disease treatment: Design, synthesis and in vitro evaluation2017 | Publication without faculty affiliation
- Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer's disease treatment2017 | Publication without faculty affiliation
- Levels of 17 beta-Hydroxysteroid Dehydrogenase Type 10 in Cerebrospinal Fluid of People with Mild Cognitive Impairment and Various Types of Dementias2015 | Central Library of Charles University, Second Faculty of Medicine
- Interactions of 17 beta-Hydroxysteroid Dehydrogenase Type 10 and Cyclophilin D in Alzheimer's Disease2020 | Second Faculty of Medicine